New Antibiotic Hits the Market to Tackle Stubborn UTIs
The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...
McKnight's Long-Term Care News2 天
FDA approves new antibiotic for uncomplicated UTIs
The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...
Daily3 天
FDA approves new oral treatment for uncomplicated UTI in adult women
The US Food and Drug Administration has approved a new oral antibiotic for treatment of uncomplicated urinary tract ...
Becker's Hospital Review2 天
FDA approves another new antibiotic
FDA approves new oral antibiotic for uncomplicated urinary tract infections in women with limited treatment options. Orylnvah shows superior response rates ...
Medpage Today on MSN6 天
FDA Approves Novel Treatment for UTIs
The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...
WebMD3 天
FDA OKs New Drug for Urinary Tract Infections
The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.
verywellhealth on MSN7 天
How Long Does a UTI Last?
A mild UTI may last days or under a week. These are sometimes called uncomplicated UTIs. Learn how long a complicated UTI ...
Medscape4 天
Primary Care Physicians Underutilize Nonantibiotic Prophylaxis for Recurrent UTIs
Nonantibiotic prophylactic options for UTIs such as methenamine hippurate remain significantly underutilized, especially for ...
Man claims E.coli infection in his penis was from a bidet – but doctors aren’t so sure
A MAN claims his member was infected with drug resistant E.coli – after using a bidet. Initially thinking he had a cold or ...
US FDA approves Iterum's treatment for urinary infection
The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial ...
FiercePharma6 天
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...
BioSpace4 天
Iterum Wins FDA Approval For Oral UTI Antibiotic, Seeks ‘Strategic Transaction’ for Asset
Orlynvah is the first oral penem approved in the U.S. and Iterum Therapeutics’ first FDA-approved product. CEO Corey Fishman ...